Bridgeway Capital Management LLC Has $397,000 Stock Holdings in Assertio Holdings, Inc. (NASDAQ:ASRT)

Bridgeway Capital Management LLC lowered its stake in shares of Assertio Holdings, Inc. (NASDAQ:ASRT) by 8.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 455,282 shares of the company’s stock after selling 43,319 shares during the period. Bridgeway Capital Management LLC owned approximately 0.48% of Assertio worth $397,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently made changes to their positions in the stock. Northern Trust Corp increased its position in Assertio by 21.3% in the 4th quarter. Northern Trust Corp now owns 227,217 shares of the company’s stock valued at $198,000 after buying an additional 39,906 shares in the last quarter. Stifel Financial Corp bought a new stake in shares of Assertio during the fourth quarter valued at approximately $27,000. Marshall Wace LLP bought a new stake in shares of Assertio during the fourth quarter valued at approximately $64,000. Geode Capital Management LLC raised its position in shares of Assertio by 2.0% during the fourth quarter. Geode Capital Management LLC now owns 1,095,911 shares of the company’s stock worth $955,000 after purchasing an additional 21,059 shares during the period. Finally, Commonwealth Equity Services LLC bought a new position in shares of Assertio in the 4th quarter worth $30,000. Institutional investors and hedge funds own 48.96% of the company’s stock.

Wall Street Analyst Weigh In

ASRT has been the topic of several research reports. StockNews.com downgraded shares of Assertio from a “buy” rating to a “hold” rating in a report on Monday. Industrial Alliance Securities set a $1.75 target price on shares of Assertio in a research report on Friday, March 14th. Finally, HC Wainwright dropped their price target on shares of Assertio from $4.00 to $3.50 and set a “buy” rating on the stock in a research report on Wednesday, March 19th.

Assertio Price Performance

ASRT opened at $0.62 on Tuesday. Assertio Holdings, Inc. has a 1 year low of $0.51 and a 1 year high of $1.80. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.01 and a quick ratio of 1.57. The company has a market capitalization of $58.94 million, a price-to-earnings ratio of -0.84, a P/E/G ratio of 3.25 and a beta of 0.32. The firm’s fifty day moving average price is $0.66 and its two-hundred day moving average price is $0.81.

Assertio (NASDAQ:ASRT) last released its quarterly earnings results on Monday, May 12th. The company reported ($0.14) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.08). Assertio had a positive return on equity of 3.79% and a negative net margin of 54.46%. The firm had revenue of $26.49 million for the quarter, compared to analysts’ expectations of $27.52 million. During the same quarter last year, the firm posted $0.04 earnings per share. As a group, analysts anticipate that Assertio Holdings, Inc. will post -0.15 earnings per share for the current fiscal year.

About Assertio

Assertio Holdings, Inc, a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis.